Evidence map›Paper›PMID 31569354›Full record

ArticleAntibiotics (Basel, Switzerland)2019

Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide.

Christian Kohler, Richard A Proctor, Arnold S Bayer, Michael R Yeaman, Michael Lalk, Susanne Engelmann, Nagendra N Mishra

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Unique structural and ligand-binding properties of theProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Unique structural and ligand binding properties of thebioRxiv : the preprint server for biology · 2025
    Article
  3. Imaging mass spectrometry reveals complex lipid distributions acrossJournal of mass spectrometry and advances in the clinical lab · 2022
    Article
  4. Review
  5. Strain-Specific Adaptations ofAntibiotics (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Christian KohlerUniversität Greifswald, Institut für Mikrobiologie und Molekularbiologie,17487 Greifswald, Germany. chritian.kohler@med.uni-greifswald.de.
Richard A ProctorUniversity of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA. rap@wisc.edu.
Arnold S BayerDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, CA 90502, USA.ORCID 0000-0003-1968-0192
Michael R YeamanDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, CA 90502, USA. mryeaman@ucla.edu.
Michael LalkUniversity Greifswald, Institute of Biochemistry, 17487 Greifswald, Germany. lalk@uni-greifswald.de.
Susanne EngelmannUniversität Greifswald, Institut für Mikrobiologie und Molekularbiologie,17487 Greifswald, Germany. Engelmann@helmholtz-hzi.de.
Nagendra N MishraDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, CA 90502, USA. nnmishra@ucla.edu.
University of California, Los Angeles · USHelmholtz Centre for Infection Research · DEUniversity of Wisconsin–Madison · US

Funding

Systems Immunolobiology of Antibiotic-Persistent MRSA InfectionU01AI124319 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2020
$10.1M
Staphylococcal Adaptations to Platelet Microbicidal ProteinR01AI039108 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 1997 to 2016
$5.1M
Mitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2M
LA Biomed-Harbor UCLA Medical Center, Torrance, CA. 531604-01-00NIAID NIH HHS R01 AI039108NIAID NIH HHS R33 AI111661NIAID NIH HHS U01 AI124319NIH HHS AI-39108NIH HHS U01-AI-124319; R33-AI-111661
6 · The paper itself

Abstract

We previously described a transposon mutant in

Indexed as

lipidsproteomicsS. aureussnoD mutanttPMP resistance

Identifiers

PMID31569354
PMCPMC6963496
OpenAlexW2975980623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.